MoneyWorks4Me

Lupin informs about press release

06 Jun 2016 Evaluate

Lupin has informed about a Press Release dated June 06, 2016 titled ‘Lupin Receives FDA Approvals for Generic Vfend Tablets 50mg, 200mg & Vfend Oral Suspension, 40 mg/mL’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..